Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program

Posted : Tue, 03 Nov 2009 12:32:09 GMT
Author : Oncolytics Biotech Inc.
Category : Press Release
News Alerts by Email ( click here )
News | Home
CALGARY, Nov. 3 Oncolytics-Program
CALGARY, Nov. 3 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Corporation") (TSX:ONC; NASDAQ:ONCY) announces, that pursuant to the accelerated expiry of those warrants issued on May 13, 2009, the Corporation has received proceeds of approximately $9.1 million resulting from the exercise of all 3,795,000 warrants. Oncolytics now has 56,662,469 shares issued and outstanding, and cash on hand and available for operations of approximately $23.7 million.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of human trials including a Phase III trial in head and neck cancers using REOLYSIN(R), its proprietary formulation of the human reovirus. For further information about Oncolytics, please visit: www.oncolyticsbiotech.com.

This press release contains forward-looking statements. Forward-looking statements, including the Company's expectations as to progress in the clinical trial program and the Company's belief as to the potential of REOLYSIN as a cancer therapeutic, involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue Research and Development projects, the efficacy of REOLYSIN as a cancer treatment, the success and timely completion of clinical studies and trials, the Company's ability to successfully commercialize REOLYSIN, uncertainties related to the research and development of pharmaceuticals, uncertainties related to the regulatory process and general changes to the economic environment. Investors should consult the Company's quarterly and annual filings with the Canadian securities commissions for additional information on risks and uncertainties relating to the forward looking statements. Investors are cautioned against placing undue reliance on forward-looking statements. The Company does not undertake to update these forward-looking statements, except as may be required pursuant to applicable securities laws.

SOURCE Oncolytics Biotech Inc.

Copyright © 2008 PR Newswire. All rights reserved.

Share/Save/Bookmark

Article : Oncolytics Biotech(R) Inc. Announces Results of Second Warrant Expiry Date Acceleration Program
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

REMINDER: Media Advisory: LAX FlyAway(R) Service Formally Inaugurates Daily Nonstop Bus Service to Irvine, Six Times Daily
LOS ANGELES, CA -- 11/22/09 -- WHAT: Los Angeles Mayor Antonio R. Villaraigosa will be joined by officials from the City of Irvine and Orange County transportation agencies to formally inaugurate the ne..

Maxprog Releases New MaxBulk Mailer 7
Maxprog is proud to present a new release of MaxBulk Mailer, new version 7, available now on Maxprog website with several interesting new features and improvements. MaxBulk Mailer is an email-merge solution for Macintosh and Windows that supports plain text, HTML and rich text formats includi...

Andean Resources Ltd.: New San Marcos Discovery at Cerro Negro
PERTH, AUSTRALIA -- 11/22/09 -- Andean Resources (TSX: AND)(ASX: AND) is pleased to report another new vein discovery from the ongoing exploration drill program at its 100% owned Cerro Negro project in Southern Argentina. Today's release includes t..

Defence Minister Declares Security Forum "World-Class" Event
HALIFAX, NOVA SCOTIA -- 11/22/09 -- As the three-day Halifax International Security Forum today wrapped up its final sessions, the Honourable Peter MacKay, Minister of National Defence and Minister for the Atlantic Gateway, declared the inaugural e..

Radiance Fine Jewelry 3rd Annual Holiday Party and Galatea Trunk Show
CHICAGO, IL -- 11/22/09 -- With the coming holidays, why give the same gift that everyone else is giving when you can come by Radiance Fine Jewelry and get something truly special. "Galatea Jewelry by Artist" has created some of the most unique pie..

The Grove’s Annual Tree Lighting Celebration and Concert, Sponsored by Cadillac, Features Special Performances, Celebrity Appearances, Lighting of the 100-ft Tree and Spectacular Fireworks Finale
LOS ANGELES - The Grove will host its annual tree-lighting event, “Hollywood Christmas Celebration at The Grove” on Sunday, November 22 at 7:30 p.m. The festive celebration, free to the public, draws crowds from throughout Los Angeles who come to see the stunning 100-foot Christm

Doctors Day Announces Exclusive Miniature Stethoscope Lapel Pin for Doctor Gift and Nurse Gift
The National Doctors' Day organization today announced the introduction of its miniature stethoscope lapel pin. At only 3/4 inches in height, it is the first realistic stethoscope lapel pin that is small enough to truly be considered a lapel pin. Unique gifts for doctors are difficult to fin...

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.